These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34671235)

  • 1. Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer's Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography.
    Willuweit A; Schöneck M; Schemmert S; Lohmann P; Bremen S; Honold D; Burda N; Jiang N; Beer S; Ermert J; Willbold D; Shah NJ; Langen KJ
    Front Neurosci; 2021; 15():699926. PubMed ID: 34671235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Stenzel J; Rühlmann C; Lindner T; Polei S; Teipel S; Kurth J; Rominger A; Krause BJ; Vollmar B; Kuhla A
    Curr Alzheimer Res; 2019; 16(1):49-55. PubMed ID: 30345916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical and clinical study on [
    Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.
    Brendel M; Jaworska A; Grießinger E; Rötzer C; Burgold S; Gildehaus FJ; Carlsen J; Cumming P; Baumann K; Haass C; Steiner H; Bartenstein P; Herms J; Rominger A
    PLoS One; 2015; 10(2):e0116678. PubMed ID: 25706990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice.
    Yousefi BH; von Reutern B; Scherübl D; Manook A; Schwaiger M; Grimmer T; Henriksen G; Förster S; Drzezga A; Wester HJ
    EJNMMI Res; 2015; 5():20. PubMed ID: 25918674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Comparison of the Amyloid-β Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis.
    Waldron AM; Verhaeghe J; wyffels L; Schmidt M; Langlois X; Van Der Linden A; Stroobants S; Staelens S
    Mol Imaging Biol; 2015 Oct; 17(5):688-96. PubMed ID: 25701131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease.
    Manook A; Yousefi BH; Willuweit A; Platzer S; Reder S; Voss A; Huisman M; Settles M; Neff F; Velden J; Schoor M; von der Kammer H; Wester HJ; Schwaiger M; Henriksen G; Drzezga A
    PLoS One; 2012; 7(3):e31310. PubMed ID: 22427802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease.
    Willuweit A; Velden J; Godemann R; Manook A; Jetzek F; Tintrup H; Kauselmann G; Zevnik B; Henriksen G; Drzezga A; Pohlner J; Schoor M; Kemp JA; von der Kammer H
    PLoS One; 2009 Nov; 4(11):e7931. PubMed ID: 19936202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of a novel BChE PET tracer as an early
    Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
    Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
    [No Abstract]   [Full Text] [Related]  

  • 16. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Relevance of [
    Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Chang Y; Li C; Yang H; Wu Y; Xu B; Zhang J; Wang R
    Front Neurosci; 2020; 14():745. PubMed ID: 32848542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.